The International Multicohort Consortium of Infectious Disease study group
AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA): F Wit, Marc vd Valk, M Hillebregt, Stichting HIV Monitoring (SHM), Amsterdam, Netherlands
The Australian HIV Observational Database (AHOD): K Petoumenos, M Law, J Hutchinson, D Rupasinghe, W Min Han, UNSW Sydney, Sydney, Australia
Austrian HIV Cohort Study (AHIVCOS): R Zangerle, H Appoyer, Medizinische Universität Innsbruck, Innsbruck, Austria
Brighton HIV cohort: J Vera, A Clarke, B Broster, L Barbour, D Carney, L Greenland, R Coughlan, Lawson Unit, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom
CHU Saint-Pierre, S De Wit, M Delforge, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium
Croatian HIV cohort: J Begovac, University Hospital of Infectious Diseases, Zagreb, Croatia
EuroSIDA Cohort: G Wandeler, CHIP, Rigshospitalet, RegionH, Copenhagen, Denmark
Frankfurt HIV Cohort Study: C Stephan, M Bucht, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany
Georgian National AIDS Health Information System (AIDS HIS): N Chkhartishvili, O Chokoshvili, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
Italian Cohort Naive Antiretrovirals (ICONA): A d’Arminio Monforte, A Rodanò, A Tavelli, I Fanti, Icona Foundation, Milan, Italy.
Modena HIV Cohort: C Mussini, V Borghi, M Menozzi, A Cervo, Università degli Studi di Modena, Modena, Italy
Nice HIV Cohort: C Pradier, E Fontas, K Dollet, C Caissotti, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Department of Public Health, UR2CA, Nice, France.
PISCIS Cohort Study: J Casabona, JM Miro, Centre Estudis Epidemiologics de ITS i VIH de Catalunya (CEEISCAT), Badalona, Spain
Royal Free Hospital Cohort: C Smith, F Lampe, M Johnson, F Burns, C Chaloner, Royal Free Hospital, University College London, London, United Kingdom
San Raffaele Scientific Institute: A Castagna, A Lazzarin, Università Vita-Salute San Raffaele, Milano, Italy
Swedish InfCare HIV Cohort: A Sönnerborg, C Carlander, P Nowak, J Vesterbacka, L Mattsson, D Carrick, K Stigsäter, Department of Infectious Diseases, Karolinska University Hospital, and Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet.
Sweden
Swiss HIV Cohort Study (SHCS): H Günthard, K Kusejko, H Bucher, University of Zurich, Zurich, Switzerland
University Hospital Bonn: JC Wasmuth, J Rockstroh, Bonn, Germany
University Hospital Cologne: JJ Vehreschild, G. Fätkenheuer, N Schulze, B Franke, Cologne, Germany
RESPOND Executive Committee
L Ryom*, M Law*, J Rooney, I McNicholl, V Vannappagari, H Garges, K Petoumenos, G Wandeler, R Zangerle, S De Wit, J Lundgren, F Burns, H Günthard, L Young, R Campo
*Chair
RESPOND Scientific Steering Committee
J Lundgren*, H Günthard*, J Kowalska, D Raben, L Ryom, J Rockstroh, L Peters, O Kirk, D Podlekareva, A Volny-Anne, N Dedes, ED Williams, N Chkhartishvili, R Zangerle, K Petoumenos, F Wit, C Necsoi, G Wandeler, C Pradier, A D’Arminio Monforte, C Mussini, H Bucher, A Sönnerborg, JJ Vehreschild, JC Wasmuth, F Berns, A Castagna, J Begiovac, J Vera, J Rooney, I McNicholl, V Vannappagari, H Garges, L Young, R Campo
*Chairs
Community Representatives:
Alain Volny-Anne, Nikos Dedes, Luis Mendão
(European AIDS Treatment Group), Esther Dixon Williams (UK)
RESPOND Staff
Coordinating Centre Staff: JF Larsen, L Peters, N Jaschinski, A Timiryasova, B Neesgaard, O Fursa, L Ryom, ML Jakobsen, C Kraef, M Gardizi
Data Management Staff: D Raben, K Andersen, L Ramesh Kumar, TW Elsing, S Shahi, O Valdenmaiier
Statistical Staff: J Reekie, L Greenberg, L Bansi-Matharu, K Petoumenos, D. Byonanebye, E Tusch, W Bannister, A Roen
Funding
The International Cohort Consortium of Infectious Disease (RESPOND) is supported by The CHU St Pierre Brussels HIV Cohort, The Austrian HIV Cohort Study, The Australian HIV Observational Database, The AIDS Therapy Evaluation in the Netherlands National Observational HIV cohort, The EuroSIDA cohort, The Frankfurt HIV Cohort Study, The Georgian National AIDS Health Information System, The Nice HIV Cohort, The ICONA Foundation, The Modena HIV Cohort, The PISCIS Cohort Study, The Swiss HIV Cohort Study, The Swedish InfCare HIV Cohort, The Royal Free HIV Cohort Study, The San Raffaele Scientific Institute, The University Hospital Bonn HIV Cohort, The University of Cologne HIV Cohort, The Brighton HIV Cohort and The National Croatian HIV cohort. RESPOND is further financially supported by ViiV Healthcare, Merck Life Sciences, Gilead Sciences, the EuroSIDA Cohort and the AHOD cohort by grant No. U01-AI069907 from the U.S. National Institutes of Health, and GNT1050874 of the National Health and Medical Research Council, Australia.